Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Safety and Efficacy of Botulinum Toxin A for Treatment of Overactive Bladder in Parkinson's Disease:Randomized Controlled Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05997043
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:37.457050+00:00
Published At
2023-08-18T00:00:00+00:00
Record Updated At
2023-08-18
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Parkinson\u0027s Disease", "Overactive Bladder", "Onabotulinumtoxin A"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-08-18"
protocolSection.identificationModule.nctId
"NCT05997043"
protocolSection.identificationModule.officialTitle
"Safety and Efficacy of Botulinum Toxin A for Treatment of Overactive Bladder in Parkinson\u0027s Disease:Randomized Controlled Trial"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["EARLY_PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Parkinson's Disease (protocolSection.conditionsModule.conditions)
  • Overactive Bladder (protocolSection.conditionsModule.conditions)
  • Onabotulinumtoxin A (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.